Drug Studies

We are proud to offer our patients participation in neurological research in keeping with our mission of providing the most advanced level of care possible.

With offices in Port Royal, Bluffton, and Hampton.

Research Trials

Coastal Neurology is proud to offer our community opportunities to participate in neurological research in keeping with our mission of providing the most advanced level of patient care possible. We have more than 20 years of clinical trial experience. Contact our dedicated research coordinator, Daisy White, at 843.522.1420 for more information.

Research Trials

Coastal Neurology is proud to offer our community opportunities to participate in neurological research in keeping with our mission of providing the most advanced level of patient care possible. We have more than 20 years of clinical trial experience. Contact our dedicated research coordinator, Daisy White, at 843.522.1420 for more information.

Alzheimer’s Disease Research

  • CLARITY-AD: Leqembi administered twice a month to eliminate amyloid plaque and slow progression in mild cognitive impairment and early Alzheimer’s Disease.
  • ENVISION: Medicare authorized trial of Aduhelm given IV once a month to eliminate amyloid plaque in Alzheimer’s Disease and slow progression.
  • HOPE: Jointly sponsored by MIT, Emory & University of Tennessee, this is a medical device that is worn an hour a day from the comfort of your home to boost electrical activity in the brain and slow Alzheimer’s Disease Progression. See hopestudyforad.com.
  • New IDEAS: A study to investigate the value of amyloid PET scans in diagnosing and treating suspected Alzheimer’s Disease.
  • EVOKE: Evaluation of an oral diabetes drug to slow progression of Alzheimer’s Disease.